Dyadic International, Inc.

Get Full Access

Description

  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-S-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and research collaborations with Jiangsu Hengrui Medicine, Serum Institute of India Pvt., Ltd., and WuXi Biologics. It also has a collaboration with TurtleTree Scientific Pte. Ltd. to develop various recombinant protein growth factors; and a partnership agreement with Medytox, Inc. and Syngene International Limited to develop COVID-19 vaccines and/or boosters. The company was founded in 1979 and is headquartered in Jupiter, Florida.
  • location

    Headquarters:140 Intracoastal Pointe Drive Suite 404, Jupiter, Florida, United States

    More
  • Dyadic International, Inc. phone

    Phone Number: +1 561-743-8333

  • Dyadic International, Inc. website

    Website: https://www.dyadic.com

  • Dyadic International, Inc. employees

    Employees:39

  • Dyadic International, Inc. revenue

    Revenue:$1 - 10M

  • Dyadic International, Inc. legal name

    Legal Name:Dyadic International, Inc.

  • Dyadic International, Inc.'s Social Media

    Dyadic International, Inc. linkedin Dyadic International, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 423990  |

      NYSE: DYAI

    Show More
Person level website identification

CEO for Dyadic International, Inc.

Wayne Moor

President Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Ronen Tchelet

Chief Scientific Officer

Ping Rawson

Chief Financial Officer

Bill Kling

Vice President Worldwide Sales

Ray Chandra

Vice President Marketing - Biological Systems

Kimberly Obst

Art Director

Frequently Asked Questions regarding Dyadic International, Inc.

  • Where are Dyadic International, Inc.'s Headquarters?

    Dyadic International, Inc.'s Headquarters are in 140 Intracoastal Pointe Drive Suite 404,Jupiter,Florida,United States

  • What is Dyadic International, Inc.'s phone number?

    Dyadic International, Inc.'s phone number is +1 561-743-8333

  • What is Dyadic International, Inc.'s stock symbol?

    Dyadic International, Inc.'s stock symbol is DYAI

  • What is Dyadic International, Inc.'s official website?

    Dyadic International, Inc.'s official website is https://www.dyadic.com

  • What is Dyadic International, Inc.'s Revenue?

    Dyadic International, Inc.'s revenue is $1 - 10M

  • What is Dyadic International, Inc.'s NAICS code?

    Dyadic International, Inc.'s NAICS code is 423990

  • How many employees are working in Dyadic International, Inc.

    Dyadic International, Inc. has 39 employees

  • What is Dyadic International, Inc.'s Industry?

    Dyadic International, Inc. is in the industry of Biotechnology

Company Directory